LENALIDOMIDE

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
21081
A phase III study of Ienalidomide maintenance after debulking with gemcitabine or liposomal doxorubicin +/- radiotherapy in patients with advanced cutaneous T-cell lymphoma not previously treated with intravenous chemotherapy

Back to Protocol section